{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T07:16:11Z","timestamp":1773731771192,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Huazhong Univ. Sci. Technol. [Med. Sci.]"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s11596-015-1528-9","type":"journal-article","created":{"date-parts":[[2015,12,15]],"date-time":"2015-12-15T21:08:14Z","timestamp":1450213694000},"page":"916-922","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Antiviral effect of emodin from Rheum palmatum against coxsakievirus B5 and human respiratory syncytial virus in vitro"],"prefix":"10.1007","volume":"35","author":[{"given":"Zhao","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhan-qiu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,16]]},"reference":[{"key":"1528_CR1","first-page":"13","volume":"233","author":"MA Pallansch","year":"1997","unstructured":"Pallansch MA. Coxsackievirus B epidemiology and public health concerns. Curr Top Microbiol Immunol, 1997,233:13\u201330","journal-title":"Curr Top Microbiol Immunol"},{"key":"1528_CR2","first-page":"241","volume":"323","author":"AI Ramsingh","year":"2008","unstructured":"Ramsingh AI. CVB-induced pancreatitis and alterations in gene expression. Curr Top Microbiol Immunol, 2008,323:241\u2013258","journal-title":"Curr Top Microbiol Immunol"},{"key":"1528_CR3","first-page":"275","volume":"323","author":"NM Chapman","year":"2008","unstructured":"Chapman NM, Kim KS. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. Curr Top Microbiol Immunol, 2008,323:275\u2013292","journal-title":"Curr Top Microbiol Immunol"},{"key":"1528_CR4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10096-007-0306-4","volume":"26","author":"D Antona","year":"2007","unstructured":"Antona D, L\u00e9v\u00eaque N, Chome JJ, et al. Surveillance of enteroviruses in France, 2000-2004. Eur J Clin Microbiol Infect Dis, 2007,26:403\u2013412","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1528_CR5","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jcv.2009.11.013","volume":"47","author":"G Trallero","year":"2010","unstructured":"Trallero G, Avellon A, Otero A, et al. Enteroviruses in Spain over the decade 1998-2007: virological and epidemiological studies. J Clin Virol, 2010,47:170\u2013176.","journal-title":"J Clin Virol"},{"issue":"4","key":"1528_CR6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00705-009-0346-4","volume":"154","author":"Q Zhong","year":"2009","unstructured":"Zhong Q, Yang Z, Liu Y, et al. Antiviral activity of arbidol against Coxsackie virus B5 in vitro and in vivo. Arch Virol, 2009,154(4):601\u2013607","journal-title":"Arch Virol"},{"key":"1528_CR7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3201\/eid1802.111524","volume":"18","author":"JF Han","year":"2012","unstructured":"Han JF, Jiang T, Fan XL, et al. Recombination of human coxsackievirus B5 in hand, foot, and mouth disease patients, China. Emerg Infect Dis, 2012,18:351\u2013353","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"1528_CR8","first-page":"339","volume":"14","author":"L I Ravi","year":"2013","unstructured":"Ravi L I, Liang L, Sutejo R, et al. A systems-based approach to analyse the host response in murine lung macrophages challenged with respiratory syncytial virus. Bmc Genomics, 2013,14(3):339\u2013342","journal-title":"Bmc Genomics"},{"issue":"9725","key":"1528_CR9","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","volume":"375","author":"H Nair","year":"2010","unstructured":"Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet, 2010,375(9725):1545\u20131555","journal-title":"Lancet"},{"issue":"11","key":"1528_CR10","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/oxfordjournals.aje.a115826","volume":"133","author":"CJ Holberg","year":"1991","unstructured":"Holberg CJ, Wright AL, Martinez FD, et al. Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life. Am J Epidemiol, 1991,133(11):1135\u20131151","journal-title":"Am J Epidemiol"},{"issue":"7","key":"1528_CR11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1056\/NEJM198208123070702","volume":"307","author":"NE MacDonald","year":"1982","unstructured":"MacDonald NE, Hall CB, Suffin SC, et al. Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med, 1982,307(7):397\u2013400","journal-title":"N Engl J Med"},{"key":"1528_CR12","doi-asserted-by":"crossref","unstructured":"Morales F, Calder MA, Inglis JM, et al. A study of respiratory infections in the elderly to assess the role of respiratory syncytial virus. J Infect,7(3):236-247","DOI":"10.1016\/S0163-4453(83)97142-6"},{"key":"1528_CR13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0166-3542(01)00206-6","volume":"53","author":"HA Rotbart","year":"2002","unstructured":"Rotbart HA. Treatment of picornavirus infections. Antiviral Res, 2002,53:83\u201398","journal-title":"Antiviral Res"},{"key":"1528_CR14","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.cll.2009.07.004","volume":"29","author":"Y Murata","year":"2009","unstructured":"Murata Y. Respiratory syncytial virus vaccine development. Clin Lab Med, 2009,29:725\u2013739","journal-title":"Clin Lab Med"},{"issue":"5","key":"1528_CR15","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1128\/AAC.48.5.1811-1822.2004","volume":"48","author":"A Mej\u00edas","year":"2004","unstructured":"Mej\u00edas A, Ch\u00e1vez-Bueno S, R\u00edos AM, et al. Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model. Antimicrob Agents Chemother, 2004,48(5):1811\u20131822","journal-title":"Antimicrob Agents Chemother"},{"key":"1528_CR16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1586\/eri.10.140","volume":"9","author":"LR Krilov","year":"2011","unstructured":"Krilov LR. Respiratory syncytial virus disease: update on treatment and prevention. Expert Rev Anti Infect Ther, 2011,9:27\u201332","journal-title":"Expert Rev Anti Infect Ther"},{"key":"1528_CR17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejphar.2007.02.033","volume":"567","author":"T Tang","year":"2007","unstructured":"Tang T, Yin LW, Yang J, et al. Emodin, an anthraquinone derivative from Rheum officinale Baill, enhances cutaneous wound healing in rats. Eur J Pharmacol, 2007,567:177\u2013185","journal-title":"Eur J Pharmacol"},{"key":"1528_CR18","first-page":"493","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed LJ, Muench HA. A simple method of estimating fifty percent endpoints. Am J Hyg, 1938,27:493\u2013497","journal-title":"Am J Hyg"},{"key":"1528_CR19","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00705-007-0974-5","volume":"152","author":"L Shi","year":"2007","unstructured":"Shi L, Xiong H, He J, et al. Antiviral activity of arbidol against influenza A virus, respiratory syncytial virus, rhinovirus, coxsackie virus and adenovirus in vitro and in vivo. Arch Virol, 2007,152:1447\u20131455","journal-title":"Arch Virol"},{"issue":"2","key":"1528_CR20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.antiviral.2005.06.010","volume":"68","author":"JM Song","year":"2005","unstructured":"Song JM, Lee KH, Seong BL. Antiviral effect of catechins in green tea on influenza virus. Antiviral Res, 2005,68(2): 66\u201374","journal-title":"Antiviral Res"},{"key":"1528_CR21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0166-3542(01)00147-4","volume":"51","author":"SL Boulware","year":"2001","unstructured":"Boulware SL, Bronstein JC, Nordby EC, et al. Identification and characterization of benzothiophene inhibitor of herpes simplex virus type 1 replication which acts at the immediate early stage of infection. Antiviral Res, 2001,51:111\u2013125","journal-title":"Antiviral Res"},{"issue":"2","key":"1528_CR22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1399-3089.2009.00522.x","volume":"16","author":"EM Dr Suzanne","year":"2009","unstructured":"Dr Suzanne EM, Rebecca L, Dr Moses KN, et al. Pathogenesis of Coxsackievirus-B5 acquired from intra-renal porcine islet cell xenografts in diabetic mice. Xenotransplantation, 2009,16(2):91\u201398","journal-title":"Xenotransplantation"},{"issue":"7","key":"1528_CR23","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.4049\/jimmunol.1001718","volume":"185","author":"J Yuan","year":"2010","unstructured":"Yuan J, Yu M, Lin QW, et al. Th17 cells contribute to viral replication in coxsackievirus B3-induced acute viral myocarditis. J Immunol, 2010,185(7):4004\u20134010","journal-title":"J Immunol"},{"issue":"3-4","key":"1528_CR24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.vetimm.2011.06.005","volume":"143","author":"C Robert-Tissot","year":"2011","unstructured":"Robert-Tissot C, Ruegger VL, Cattori V, et al. The innate antiviral immune system of the cat: molecular tools for the measurement of its state of activation. Vet Immunol Immunopathol, 2011,143(3-4):269\u2013281","journal-title":"Vet Immunol Immunopathol"},{"key":"1528_CR25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 2001,25:402\u2013408","journal-title":"Methods"},{"issue":"12","key":"1528_CR26","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0006-2952(02)01386-2","volume":"64","author":"YC Chen","year":"2002","unstructured":"Chen YC, Shen SC, Lee WR, et al. Emodin induces apoptosis in human promyeloleukemic HL-60 cells accompanied by activation of caspase 3 cascade but independent of reactive oxygen species production. Biochem Pharmacol, 2002,64(12):1713\u20131724","journal-title":"Biochem Pharmacol"},{"key":"1528_CR27","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/sj.onc.1201998","volume":"17","author":"A Kumar","year":"1998","unstructured":"Kumar A, Dhawan S, Aggarwal BB. Emodin (3-methyl-1,6,8-trihydroxyanthraquinone) inhibits TNFinduced NF-kB activation, I?B degradation, and expression of cell surface adhesion proteins in human vascular endothelial cells. Oncogene, 1998,17:913\u2013918","journal-title":"Oncogene"},{"key":"1528_CR28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/bjp.2008.242","volume":"155","author":"CY Hsiang","year":"2008","unstructured":"Hsiang CY, Ho TY. Emodin is a novel alkaline nuclease inhibitor that suppresses herpes simplex virus type 1 yields in cell cultures. Br J Pharmacol, 2008,155:227\u2013235","journal-title":"Br J Pharmacol"},{"key":"1528_CR29","first-page":"BR302","volume":"12","author":"D Shuangsuo","year":"2006","unstructured":"Shuangsuo D, Zhengguo Z, Yunru C, et al. Inhibition of the replication of hepatitis B virus in vitro by emodin. Med Sci Monit, 2006, 12:BR302\u2013BR306","journal-title":"Med Sci Monit"},{"key":"1528_CR30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.antiviral.2011.02.008","volume":"90","author":"S Schwarz","year":"2011","unstructured":"Schwarz S, Wang K, Yu W, et al. Emodin inhibits current through SARS-associated coronavirus 3a protein. Antiviral Res, 2011,90:64\u201369","journal-title":"Antiviral Res"},{"key":"1528_CR31","doi-asserted-by":"crossref","first-page":"29618","DOI":"10.1074\/jbc.M004257200","volume":"275","author":"R Battistutta","year":"2000","unstructured":"Battistutta R, Sarno S, De Moliner E, et al. The replacement of ATP by the competitive inhibitor emodin induces conformational modifications in the catalytic site of protein kinase CK2. J Biol Chem, 2000,275:29618\u201329622","journal-title":"J Biol Chem"},{"key":"1528_CR32","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1128\/AAC.35.12.2463","volume":"35","author":"RJ Sydiskis","year":"1991","unstructured":"Sydiskis RJ, Owen DG, Lohr JL, et al. Inactivation of enveloped viruses by anthraquinones extracted from plants. Antimicrob Agents Chemother, 1991,35:2463\u20132466","journal-title":"Antimicrob Agents Chemother"},{"issue":"1-2","key":"1528_CR33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jviromet.2011.12.016","volume":"180","author":"Q Kan","year":"2012","unstructured":"Kan Q, Li D, Yu Z. Specific expression of human interferon-gamma controls hepatitis B virus replication in vitro in secreting hepatitis B surface antigen hepatocytes. Virol Methods, 2012,180(1-2):84\u201390","journal-title":"Virol Methods"},{"issue":"7","key":"1528_CR34","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1128\/JVI.01496-10","volume":"85","author":"SR Stubblefield Park","year":"2011","unstructured":"Stubblefield Park SR, Widness M, Levine A D, et al. T cell-, interleukin-12-, and gamma interferon-driven viral clearance in measles virus-infected brain tissue. J Virol, 2011,85(7):3664\u20133676","journal-title":"J Virol"},{"key":"1528_CR35","doi-asserted-by":"crossref","first-page":"8187","DOI":"10.1128\/JVI.75.17.8187-8194.2001","volume":"75","author":"A Henke","year":"2001","unstructured":"Henke A, Zell R, Ehrlich G, et al. Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis. J Virol, 2001,75:8187\u20138194.","journal-title":"J Virol"},{"key":"1528_CR36","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.RES.85.6.551","volume":"85","author":"MA Opavsky","year":"1999","unstructured":"Opavsky MA, Penninger J, Aitken K, et al. Susceptibility to myocarditis is dependent on the response of alpha\/beta T lymphocytes to coxsackieviral infection. Circ Res, 1999, 85:551\u2013558","journal-title":"Circ Res"},{"key":"1528_CR37","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1128\/JVI.73.3.1756-1766.1999","volume":"73","author":"MS Horwitz","year":"1999","unstructured":"Horwitz MS, Krahl T, Fine C, et al. Protection from lethal coxsackievirus-induced pancreatitis by expression of gamma interferon. J Virol, 1999,73:1756\u20131766","journal-title":"J Virol"},{"key":"1528_CR38","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.lfs.2004.03.012","volume":"75","author":"T Kanda","year":"2004","unstructured":"Kanda T, Takahashia T, Kudob S, et al. Leptin deficiency enhances myocardial necrosis and lethality in a murine model of viral myocarditis. Life Sci, 2004,75:1435\u20131447","journal-title":"Life Sci"},{"key":"1528_CR39","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.micinf.2004.12.011","volume":"7","author":"SA Huber","year":"2005","unstructured":"Huber SA, Born W, O\u2019Brien R. Dual functions of murine CD cells in inflammation and autoimmunity in coxsackievirus B3-induced myocarditis: role of Vc1+ and Vc4+ cells. Microbes Infect, 2005,7:537\u2013543","journal-title":"Microbes Infect"}],"container-title":["Journal of Huazhong University of Science and Technology [Medical Sciences]"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-015-1528-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11596-015-1528-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-015-1528-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T18:39:40Z","timestamp":1599935980000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11596-015-1528-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1528"],"URL":"https:\/\/doi.org\/10.1007\/s11596-015-1528-9","relation":{},"ISSN":["1672-0733","1993-1352"],"issn-type":[{"value":"1672-0733","type":"print"},{"value":"1993-1352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}